In vitro evaluation of dual-antigenic PV1 peptide vaccine in head and neck cancer patients

Peptide vaccines derived from tumour-associated antigens have been used as an immunotherapeutic approach to induce specific cytotoxic immune response against tumour. We previously identified that MAGED4B and FJX1 proteins are overexpressed in HNSCC patients; and further demonstrated that two HLA-A2-...

Disgrifiad llawn

Wedi'i Gadw mewn:
Manylion Llyfryddiaeth
Cyhoeddwyd yn:Hum Vaccin Immunother
Prif Awduron: Chai, San Jiun, Fong, Sammuel Chee Yong, Gan, Chai Phei, Pua, Kin Choo, Lim, Paul Vey Hong, Lau, Shin Hin, Zain, Rosnah Binti, Abraham, Thomas, Ismail, Siti Mazlipah, Abdul Rahman, Zainal Ariff, Ponniah, Sathibalan, Patel, Vyomesh, Cheong, Sok Ching, Lim, Kue Peng
Fformat: Artigo
Iaith:Inglês
Cyhoeddwyd: Taylor & Francis 2018
Pynciau:
Research Paper
Mynediad Ar-lein:https://ncbi.nlm.nih.gov/pmc/articles/PMC6363157/
https://ncbi.nlm.nih.gov/pubmed/30193086
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/21645515.2018.1520584
Tagiau: Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!

Eitemau Tebyg